Daytrana for Health Care Providers >Benefits of Daytrana > Physician Resources

Physician Resources

Help patients and parents understand ADHD and have the best experience possible with Daytrana. From diagnosis through treatment, the following resources can help make it easier to manage ADHD symptoms:

Medscape ADHD Condition Site
The Medscape ADHD Condition Site sponsored by Shire includes articles on important topics in ADHD, including discussions with ADHD thought leaders. Medscape registration is required.

Medscape ADHD Franchise Site
The Medscape ADHD Franchise Site sponsored by Shire is a comprehensive resource for information on Shire ADHD treatments, publications, and clinical information. Medscape registration is required.

American Psychological Association
The latest on ADHD news, studies, and treatments from the American Psychological Association (APA) Online.

Psychiatry Online
PsychiatryOnline.com offers a collection of psychiatric references—including books and journals—on ADHD and other psychiatric disorders. You can get instant access to references, journals, self-assessment tools, and clinical and research news.

eMedicine
eMedicine, from WebMD, is the largest and most current clinical knowledge base available to physicians and other healthcare professionals. The ADHD resource center within eMedicine, features patient education materials, PDA and newsletter downloads, journal abstracts, and other valuable ADHD-related resources for Physicians in a conveniently organized manner.

For Your Patients

ADHDSupport.com
Provides ADHD facts, and features tools and resources designed for multiple patient types.

Winning With ADHD
This site, published by Frank Giovinazzi, aims to provide readers with practical solutions to succeeding with Attention Deficit Disorder. It is an anecdotal resource compiled by a writer who considers himself blessed with what others see as an affliction.

About: ADD/ADHD
Suggestions and tips for parents working with preschool children with ADD/ADHD.

ADHDNews.com
ADHDNews.com is a community started by Brandi Valentine in 1995. This site contains the latest information about ADHD and links to ADHD support networks for parents.

Healthplace.com
User-friendly site that provides support, information, and friendship for both parents and children with ADHD.

Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD)
Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) is a national nonprofit, tax-exempt (Section 501 (c) (3)) organization providing education, advocacy, and support for individuals with ADHD.

NewIdeas.net
Comprehensive resources for both parents and teachers, providing education and creative ideas for classroom use.

Surgeon General Website
Report of the Surgeon General addressing ADHD in children. A good resource for facts and figures.

Important Safety Information

Daytrana should not be used in patients with allergy to methylphenidate or patch components; marked anxiety, tension and agitation; glaucoma; tics, diagnosis or a family history of Tourette's syndrome; seizures; or during or within 14 days after treatment with monoamine oxidase inhibitors (MAOIs).

Sudden death has been reported in association with CNS stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems. Sudden deaths, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses in ADHD. Physicians should take a careful patient history, including family history, and physical exam to assess the presence of cardiac disease. Patients who report symptoms of cardiac disease such as exertional chest pain and unexplained syncope should be promptly evaluated. Use with caution in patients whose underlying medical condition might be affected by increases in blood pressure or heart rate.

New psychosis, mania, aggression, growth suppression, and visual disturbances have been associated with the use of stimulants. Use with caution in patients with a history of: psychosis; EEG abnormalities; bipolar disorder; depression. Growth and hematologic monitoring is advised during prolonged treatment. Patients should avoid applying external heat to the Daytrana patch. Erythema has been commonly reported. Contact sensitization may occur.

Daytrana should be given cautiously to patients with a history of drug dependence and alcoholism. Chronic abuse can lead to marked tolerance and psychological dependence. Frank psychotic episodes can occur, especially with parenteral abuse. Careful supervision is required during withdrawal from abusive use, since severe depression may occur. Withdrawal following chronic therapeutic use may unmask symptoms of the underlying disorder.

Common adverse events reported by patients who received Daytrana in clinical trials were decreased appetite, insomnia, nausea, vomiting, decreased weight, tics, affect lability, and anorexia, consistent with adverse events commonly associated with the use of methylphenidate.

Shire ©2008 Shire US Inc., Wayne, PA 19087-5367, (800) 828-2088. All rights reserved.

Daytrana® is a registered trademark of Shire Pharmaceuticals Ireland Limited.

DAY-00032   08/08

This site is strictly intended for U.S. residents and is governed solely by U.S. laws and governmental regulations. Please see our online privacy policy for more information.

While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.